Copyright Reports & Markets. All rights reserved.

Global Ocular Drug Delivery Sales Market Report 2021

Request for Sample of this report
Buy now

1 Ocular Drug Delivery Market Overview

  • 1.1 Ocular Drug Delivery Product Scope
  • 1.2 Ocular Drug Delivery Segment by Type
    • 1.2.1 Global Ocular Drug Delivery Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Ocular Insert
    • 1.2.3 Iontophoresis
    • 1.2.4 Intraocular Implants
    • 1.2.5 In Situ Gel & Punctal Plugs
    • 1.2.6 Others
  • 1.3 Ocular Drug Delivery Segment by Application
    • 1.3.1 Global Ocular Drug Delivery Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospitals
    • 1.3.3 Ambulatory Surgical Centers
    • 1.3.4 Ophthalmic Clinics
    • 1.3.5 Homecare Settings
  • 1.4 Ocular Drug Delivery Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Ocular Drug Delivery Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Ocular Drug Delivery Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Ocular Drug Delivery Price Trends (2016-2027)

2 Ocular Drug Delivery Estimates and Forecasts by Region

  • 2.1 Global Ocular Drug Delivery Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Ocular Drug Delivery Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Ocular Drug Delivery Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Ocular Drug Delivery Revenue Market Share by Region (2016-2021)
  • 2.3 Global Ocular Drug Delivery Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Ocular Drug Delivery Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Ocular Drug Delivery Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Ocular Drug Delivery Estimates and Projections (2016-2027)
    • 2.4.2 Europe Ocular Drug Delivery Estimates and Projections (2016-2027)
    • 2.4.3 China Ocular Drug Delivery Estimates and Projections (2016-2027)
    • 2.4.4 Japan Ocular Drug Delivery Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Ocular Drug Delivery Estimates and Projections (2016-2027)
    • 2.4.6 India Ocular Drug Delivery Estimates and Projections (2016-2027)

3 Global Ocular Drug Delivery Competition Landscape by Players

  • 3.1 Global Top Ocular Drug Delivery Players by Sales (2016-2021)
  • 3.2 Global Top Ocular Drug Delivery Players by Revenue (2016-2021)
  • 3.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2020)
  • 3.4 Global Ocular Drug Delivery Average Price by Company (2016-2021)
  • 3.5 Manufacturers Ocular Drug Delivery Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Ocular Drug Delivery Market Size by Type

  • 4.1 Global Ocular Drug Delivery Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Ocular Drug Delivery Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Ocular Drug Delivery Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Ocular Drug Delivery Price by Type (2016-2021)
  • 4.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Ocular Drug Delivery Price Forecast by Type (2022-2027)

5 Global Ocular Drug Delivery Market Size by Application

  • 5.1 Global Ocular Drug Delivery Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Ocular Drug Delivery Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Ocular Drug Delivery Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Ocular Drug Delivery Price by Application (2016-2021)
  • 5.2 Global Ocular Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2022-2027)

6 North America Ocular Drug Delivery Market Facts & Figures

  • 6.1 North America Ocular Drug Delivery Sales by Company
    • 6.1.1 North America Ocular Drug Delivery Sales by Company (2016-2021)
    • 6.1.2 North America Ocular Drug Delivery Revenue by Company (2016-2021)
  • 6.2 North America Ocular Drug Delivery Sales Breakdown by Type
    • 6.2.1 North America Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
  • 6.3 North America Ocular Drug Delivery Sales Breakdown by Application
    • 6.3.1 North America Ocular Drug Delivery Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Ocular Drug Delivery Sales Breakdown by Application (2022-2027)

7 Europe Ocular Drug Delivery Market Facts & Figures

  • 7.1 Europe Ocular Drug Delivery Sales by Company
    • 7.1.1 Europe Ocular Drug Delivery Sales by Company (2016-2021)
    • 7.1.2 Europe Ocular Drug Delivery Revenue by Company (2016-2021)
  • 7.2 Europe Ocular Drug Delivery Sales Breakdown by Type
    • 7.2.1 Europe Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Ocular Drug Delivery Sales Breakdown by Application
    • 7.3.1 Europe 125 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 125 Sales Breakdown by Application (2022-2027)

8 China Ocular Drug Delivery Market Facts & Figures

  • 8.1 China Ocular Drug Delivery Sales by Company
    • 8.1.1 China Ocular Drug Delivery Sales by Company (2016-2021)
    • 8.1.2 China Ocular Drug Delivery Revenue by Company (2016-2021)
  • 8.2 China Ocular Drug Delivery Sales Breakdown by Type
    • 8.2.1 China Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
  • 8.3 China Ocular Drug Delivery Sales Breakdown by Application
    • 8.3.1 China 154 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 154 Sales Breakdown by Application (2022-2027)

9 Japan Ocular Drug Delivery Market Facts & Figures

  • 9.1 Japan Ocular Drug Delivery Sales by Company
    • 9.1.1 Japan Ocular Drug Delivery Sales by Company (2016-2021)
    • 9.1.2 Japan Ocular Drug Delivery Revenue by Company (2016-2021)
  • 9.2 Japan Ocular Drug Delivery Sales Breakdown by Type
    • 9.2.1 Japan Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Ocular Drug Delivery Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Ocular Drug Delivery Market Facts & Figures

  • 10.1 Southeast Asia Ocular Drug Delivery Sales by Company
    • 10.1.1 Southeast Asia Ocular Drug Delivery Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Ocular Drug Delivery Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type
    • 10.2.1 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Ocular Drug Delivery Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Ocular Drug Delivery Market Facts & Figures

  • 11.1 India Ocular Drug Delivery Sales by Company
    • 11.1.1 India Ocular Drug Delivery Sales by Company (2016-2021)
    • 11.1.2 India Ocular Drug Delivery Revenue by Company (2016-2021)
  • 11.2 India Ocular Drug Delivery Sales Breakdown by Type
    • 11.2.1 India Ocular Drug Delivery Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Ocular Drug Delivery Sales Breakdown by Type (2022-2027)
  • 11.3 India Ocular Drug Delivery Sales Breakdown by Application
    • 11.3.1 India Ocular Drug Delivery Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Ocular Drug Delivery Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Ocular Drug Delivery Business

  • 12.1 OCULAR THERAPEUTIX, INC
    • 12.1.1 OCULAR THERAPEUTIX, INC Corporation Information
    • 12.1.2 OCULAR THERAPEUTIX, INC Business Overview
    • 12.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
    • 12.1.5 OCULAR THERAPEUTIX, INC Recent Development
  • 12.2 Alimera Sciences
    • 12.2.1 Alimera Sciences Corporation Information
    • 12.2.2 Alimera Sciences Business Overview
    • 12.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
    • 12.2.5 Alimera Sciences Recent Development
  • 12.3 Allergan, Plc
    • 12.3.1 Allergan, Plc Corporation Information
    • 12.3.2 Allergan, Plc Business Overview
    • 12.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
    • 12.3.5 Allergan, Plc Recent Development
  • 12.4 EyeGate Pharma
    • 12.4.1 EyeGate Pharma Corporation Information
    • 12.4.2 EyeGate Pharma Business Overview
    • 12.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
    • 12.4.5 EyeGate Pharma Recent Development
  • 12.5 Valeant Pharmaceuticals International, Inc
    • 12.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
    • 12.5.2 Valeant Pharmaceuticals International, Inc Business Overview
    • 12.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
    • 12.5.5 Valeant Pharmaceuticals International, Inc Recent Development
  • 12.6 Envisia Therapeutics
    • 12.6.1 Envisia Therapeutics Corporation Information
    • 12.6.2 Envisia Therapeutics Business Overview
    • 12.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
    • 12.6.5 Envisia Therapeutics Recent Development
  • 12.7 Clearside Biomedical
    • 12.7.1 Clearside Biomedical Corporation Information
    • 12.7.2 Clearside Biomedical Business Overview
    • 12.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
    • 12.7.5 Clearside Biomedical Recent Development
  • 12.8 Graybug Vision Inc
    • 12.8.1 Graybug Vision Inc Corporation Information
    • 12.8.2 Graybug Vision Inc Business Overview
    • 12.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
    • 12.8.5 Graybug Vision Inc Recent Development
  • 12.9 Taiwan Liposome Company
    • 12.9.1 Taiwan Liposome Company Corporation Information
    • 12.9.2 Taiwan Liposome Company Business Overview
    • 12.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
    • 12.9.5 Taiwan Liposome Company Recent Development
  • 12.10 Santen Pharmaceutical
    • 12.10.1 Santen Pharmaceutical Corporation Information
    • 12.10.2 Santen Pharmaceutical Business Overview
    • 12.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
    • 12.10.5 Santen Pharmaceutical Recent Development

13 Ocular Drug Delivery Manufacturing Cost Analysis

  • 13.1 Ocular Drug Delivery Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Ocular Drug Delivery
  • 13.4 Ocular Drug Delivery Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Ocular Drug Delivery Distributors List
  • 14.3 Ocular Drug Delivery Customers

15 Market Dynamics

  • 15.1 Ocular Drug Delivery Market Trends
  • 15.2 Ocular Drug Delivery Drivers
  • 15.3 Ocular Drug Delivery Market Challenges
  • 15.4 Ocular Drug Delivery Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Ocular Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Ocular Insert
    Iontophoresis
    Intraocular Implants
    In Situ Gel & Punctal Plugs
    Others

    Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Ophthalmic Clinics
    Homecare Settings

    The Ocular Drug Delivery market is analysed and market size information is provided by regions (countries). Segment by Application, the Ocular Drug Delivery market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    OCULAR THERAPEUTIX, INC
    Alimera Sciences
    Allergan, Plc
    EyeGate Pharma
    Valeant Pharmaceuticals International, Inc
    Envisia Therapeutics
    Clearside Biomedical
    Graybug Vision Inc
    Taiwan Liposome Company
    Santen Pharmaceutical

    Buy now